Your browser doesn't support javascript.
loading
[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis]. / Differenzialdiagnose myelproliferativer Neoplasien. Quantitative NF-E2-Immunhistochemie zur Unterscheidung zwischen essenzieller Thrombozythämie und primärer Myelofibrose.
Aumann, K; Frey, A-V; May, A M; Hauschke, D; Kreutz, C; Marx, J P; Timmer, J; Werner, M; Pahl, H L.
Affiliation
  • Aumann K; Institut für Pathologie, Universitätsklinikum Freiburg, Breisacher Str. 115a, 79106, Freiburg, Deutschland, Konrad.Aumann@uniklinik-freiburg.de.
Pathologe ; 34 Suppl 2: 201-9, 2013 Nov.
Article in De | MEDLINE | ID: mdl-24196613

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Awards and Prizes / Bone Marrow / NF-E2 Transcription Factor, p45 Subunit / Primary Myelofibrosis / Thrombocythemia, Essential Type of study: Diagnostic_studies Limits: Humans Language: De Journal: Pathologe Year: 2013 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Awards and Prizes / Bone Marrow / NF-E2 Transcription Factor, p45 Subunit / Primary Myelofibrosis / Thrombocythemia, Essential Type of study: Diagnostic_studies Limits: Humans Language: De Journal: Pathologe Year: 2013 Document type: Article Country of publication: